: A medical supply behemoth that raised $6.26 billion in 2025; shares have climbed steadily from a $29 debut to over $41.

The following companies are widely considered the most anticipated listings for 2026 based on private valuations and market dominance:

: Valued at $42 billion to $66 billion , it recently reported annual recurring revenue of $4 billion and 265 million monthly active users. Best-Performing Recent IPOs (2025–2026)

If you are looking for stocks already trading, these recent entries have shown significant momentum: